Overview

Safety and Efficacy Study of rAAV2-ND4 Treatment of Leber Hereditary Optic Neuropathy (LHON)

Status:
Completed
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
This study is meant to assess the safety and efficacy of rAAV2-ND4 treatment of Leber hereditary optic neuropathy with 11778 LHON mutation.
Phase:
N/A
Details
Lead Sponsor:
Bin Li
Collaborator:
Huazhong University of Science and Technology